You are here

Gilead Sciences' patent loss to Merck started with a broken friendship


IF Gilead Sciences Inc has to pay Merck & Co US$2.54 billion in patent royalties, it may come down to the details of what happened between two scientists who once were close friends.

Merck claims its Idenix unit, which it bought in 2014 for about US$3.85 billion,

Market voices on:


Receive $80 Grab vouchers valid for use on all Grab services except GrabHitch and GrabShuttle when you subscribe to BT All-Digital at only $0.99*/month.

Find out more at

Powered by GET.comGetCom